The Effect of Standard Concentration Infusions on Medication Errors in Neonatal and Pediatric Healthcare Settings: A Systematic Review
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Standard concentrations (SCs) for intravenous (IV) infusions may reduce medication errors in neonates and children. While SCs showed significant risk reduction for many errors, further research is needed to confirm their long-term impact.
Area Of Science
- Pediatric Pharmacology
- Patient Safety
- Health Informatics
Background
- Neonates and children face high risks of medication errors (ME) with intravenous (IV) therapies.
- Individualized, weight-based concentrations increase variability and potential for errors.
- Standard concentrations (SCs) are proposed to enhance safety and streamline medication processes.
Purpose Of The Study
- To systematically evaluate the impact of SCs for continuous IV infusions on ME rates in neonatal and pediatric populations.
- To assess the effectiveness of SCs in reducing medication variability and improving safety.
Main Methods
- A systematic review adhering to PRISMA guidelines was conducted.
- Searched MEDLINE, Embase, and CINAHL databases (inception–August 2025).
- Included studies implementing SCs for pediatric IV infusions and measuring ME rates.
Main Results
- Five uncontrolled before-after studies (2005–2020) were analyzed.
- Relative risk reductions for overall ME ranged from 41.2% to 95.1%.
- Some error types saw increased risk, but benefits included fewer calculation/preparation errors and improved workflow.
Conclusions
- SCs show potential for safer IV infusion practices in pediatric settings, especially with technology and training.
- Current evidence is limited and heterogeneous.
- Larger, prospective studies are necessary to validate the long-term effects of SCs on pediatric ME rates.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...